Dr. Isaac Turner, Ph.D., Co-Founder and Chief Technology Officer at Curative, a next-generation healthcare company that pivoted to COVID testing in March 2020, talks about the predicament we’re in with COVID still on the rise with fewer people testing and the challenge of accessing reliable, real-time COVID data. Isaac talks about why testing is still relevant and just as important as it was in March 2020 and why testing needs to become part of our "new normal" as we enter the next phase of the virus.

#Curative

Dr. Turner is Chief Technology Officer, a co-founder, and Head of Vaccine of Curative Inc. He holds a PhD in Bioinformatics from Oxford in DNA sequence analysis. He has developed algorithms for interpreting Illumina and Oxford Nanopore sequencing data and is passionate about taking technical innovation into the clinic and scaling these processes. Previously at an a16z-backed biotech startup, Dr. Turner helped establish a clinical lab offering novel antibiotic susceptibility tests.

свернуть